Post-Trial Considerations and Dissemination
Post-Trial Communication Approaches in the Pharmaceutical Sector
The pharmaceutical industry has a need to state that a clinical trial is not over when the final patient visit has occurred
Pharma Impact Strategies at the Post-Trial Phase
The process of a new drug does not stop the minute the final patient gets out of the clinical trial location
